miR-29a amelioration of myocardial hypertrophy is explained through its effect on the nuclear receptor peroxisome proliferator-activated receptor delta (PPARD) and through downregulation of the atrial natriuretic factor [62]. This evidence concerns the gene PPARD and cardiac hypertrophy.